| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |